Breast Cancer With Over-expression of erbB2-BRAINSTORM
Clinical trial NCT01064349 · COMPLETED
Trial details
- NCT number
- NCT01064349
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-05-06
- Primary completion
- 2011-06-03
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.